Current evidence and future perspectives on the effective practice of patient-centered laboratory medicine

Clinical Chemistry

Volumn 61, Issue 4, 2015, Pages 589-599

  Hallworth, Mike J ^a   Epner, Paul L ^b   Ebert, Christoph ^c   Fantz, Corinne R ^d   Faye, Sherry A ^e   Higgins, Trefor N ^f   Kilpatrick, Eric S ^g   Li, Wenzhe ^h   Rana, S V ⁱ   Vanstapel, Florent ^j  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b Paul Epner LLC   (United States)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d Labsource LLC   (United States)

^e BECKMAN COULTER INC   (United States)

^f DynaLIFE Dx   (Canada)

^g HULL ROYAL INFIRMARY   (United Kingdom)

^h NMS Labs   (United States)

ⁱ POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; CLINICAL LABORATORY; CLINICAL MEDICINE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HUMAN; LABORATORY PERSONNEL; PATIENT CARE; PATIENT SAFETY; POINT OF CARE TESTING; REVIEW; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; PERSONALIZED MEDICINE; PROCEDURES; QUALITY CONTROL; STANDARDS; TREATMENT OUTCOME; UTILIZATION; VALIDATION STUDY;

BIOLOGICAL MARKER;

BENCHMARKING; BIOLOGICAL MARKERS; DIAGNOSTIC TESTS, ROUTINE; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; TREATMENT OUTCOME; VALIDATION STUDIES AS TOPIC;

EID: 84925733346     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2014.232629     Document Type: Review

References (76)

1. Hallworth MJ. The 70% claim: what is the evidence base? Ann Clin Biochem 2011; 48:487-8.
2. Research and Markets. Invitro diagnostics (IVD) market, techniques and applications. Dublin: Research and Markets; 2013. http://www.researchandmarkets.com/publication/pfdniq/in-vitro-diagnostic-ivd-market-technique (Accessed September 2014).
3. Gambino SR. Met and unmet needs of the automated clinical laboratory. Trans N Y Acad Sci 1970; 32(7 Series II):816-20.
4. Lundberg GD. Acting on significant laboratory results. JAMA 1981; 245:1762-3.
5. Drummond MF, Sculpher MJ, Torrance G.W., O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford; Oxford Medical Publications: 2005.
6. The Lewin Group. The value of laboratory screening and diagnostic tests for prevention and health care improvement. http://www.lewin.com/publications/publication/403/ (Accessed September 2014).
7. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91:434-7.
8. National hospital ambulatory medical care survey: 2010 Emergency department summary tables. http://www.cdc.gov/nchs/data/ahcd/nhamcs-emergency/2010-ed-web-tables.pdf (Accessed September 2014).
9. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17:204.
10. Urban TJ, Goldstein DB. Pharmacogenetics at 50: genomic personalization comes of age. Sci Transl Med 2014; 6:220ps1.
11. McGlynn EA, Asch SM, Adams J, Keesey J., Hicks J, De-Cristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003; 348: 2635-45.
12. The Lewin Group. The value of diagnostics: innovation, adoption and diffusion into health care. http://www.lewin.com/publications/Publication/237/ (Accessed September 2014).
13. The Lewin Group. Laboratory medicine: a national status report. http://www.lewin.com/publications/publication/343/ (Accessed September 2014).
14. Epner PL. Achieving the promise of point-of-care testing. Point Care 2014; 13:112-3.
15. Bingisser R, Cairns C, Christ M., Hausfater P, Lindahl B, Mair J., et al. Cardiac troponin: a critical review of the case for point-of-care testing in the ED. Am J Emerg Med 2012; 30:1639-49.
16. Heneghan P, Alonso-Coello J, Garcia-Alamino JM, Perera R, Meats E., Glasziou P. Self-monitoring of oral anticoagulants: a systematic review and meta-analysis. Lancet 2006; 367:404-11.
17. Jang JY, Shin SD, Lee E.J., Park CB, Song KJ, Singer AJ. Use of a comprehensive metabolic panel point-of-care test to reduce length of stay in the emergency department: a randomised controlled trial. Ann Emerg Med 2013; 61:145-51.
18. Lee-Lewandrowski E, Lewandrowski K. Perspectives on cost and outcomes for POCT. Clin Lab Med 2009; 29: 479-89.
19. Hernandez JS. Cost-effectiveness of laboratory testing. Arch Pathol Lab Med 2003; 127:440-5.
20. Fang CH, Otero HJ, Greenberg D, Neumann PJ. Costutility analyses of laboratory tests: a systematic review. Value Health 2011; 14:1010-8.
21. Levinson, DR. Comparing lab test payment rates: Medicare could achieve substantial savings. US Department of Health and Human Services, Office of the Inspector General 2013; OEI-07-11-00010.
22. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012; 344:e3502.
23. Epner PL, Gans JE, Graber ML. When diagnostic testing leads to harm: a new outcomes-based approach for laboratory medicine. BMJ Qual Saf 2013; 22(SUPPL. 2):ii6-10.
24. Astion M, Shojania KG, Hamill T.R., Kim S., Ng VL. Classifying laboratory incident reports to identify problems that jeopardize patient safety. Am J Clin Pathol 2003; 120:18-26.
25. Plebani M. Detection and prevention of errors in laboratory medicine. Ann Clin Biochem 2010; 47:101-10.
26. Plebani M. Laboratory-associated and diagnostic errors: a neglected link. Diagnosis 2014; 1:89-94.
27. Miller WG, Myers GL, Gantzer M.L., Kahn SE, Schonbrunner R, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011; 57:1108-17.
28. Kost GJ, Hale KN. Global trends in critical values practices and their harmonization. Clin Chem Lab Med 2011; 49:167-76.
29. Bissell MG. Laboratory-related measures of patient outcomes: an introduction. Washington; AACC Press: 2000. p 194.
30. Institute of Medicine. Crossing the Quality Chasm: a new health system for the 21st century. Washington (DC): National Academy Press: 2001.
31. Moons KGM, de Groot JAH, Linnet K, Reitsma JBR, Bossuyt PMM. Quantifying the added value of a diagnostic test or marker. Clin Chem 2012; 58:1408-17.
32. Anonychuk A, Beastall G, Shorter F., Kloss-Wolf R, Neumann P. A framework for assessing the value of laboratory diagnostics. Health Manage Forum 2012; 25:S4-11.
33. Bossuyt PM, McCaffrey K. Additional patient outcomes and pathwaysine valuations of testing. Med Decis Making 2009; 29:E30-8.
34. Lee DW, Neumann PJ, Rizzo JA. Understanding the medical and nonmedical value of diagnostic testing. Value Health 2010; 13:310-4.
35. Hickner J, Thompson PJ, Wilkinson T, Epner P., Sheehan M, Pollock AM, et al. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med 2014; 27:268-74.
36. Epner P, Astion M. Focusing on test ordering practices to cut diagnostic errors. Clin Lab News 2012; 38(7); 17-18.
37. Plebani M. Interpretative commenting: a tool for improving the laboratory/clinician interface. Clin Chim Acta 2009; 404:46-51.
38. Laposata M. Errors in clinical laboratory test selection and result interpretation: commonly unrecognised mistakes as a cause of poor patient outcome. Diagnosis 2014; 1:85-7.
39. Zhi M, Ding EL, Theisen-Toupal J, Whelan J., Arnaout R. The landscape of inappropriate laboratory testing: A 15-year meta-analysis. PLoS ONE 2013; 8:e78962.
40. Groopman J. How doctors think. New York; Houghton Mifflin: 2007.
41. Gandhi TK, Kachalia A, Thomas E.J., Puopolo AL, Yoon C, Brennan TA, et al. Missed and delayed diagnoses inthe ambulatory setting: a study of closed malpractice claims. Ann Intern Med 2006; 145:488-96.
42. Black WC. Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol 1998; 27:116-22.
43. McGregor MJ, Martin D. Testing 1, 2, 3: is overtesting undermining patient and system health? Can Fam Physician 2012; 58:1191-8.
44. Wu AHB, Bolger AF, Hollander JE. Growing pains with the useofhigh-sensitivity cardiac troponin assays. J Am Coll Cardiol 2013; 62:1250-1.
45. Hoerger TJ, Wittenborn JS, Young W. A cost-benefit analysis of lipid standardization in the United States. Prev Chronic Dis 2011; 8:A136.
46. World Alliance for Patient Safety. Summary of the evidence on patient safety: implications for research. Geneva; World Health Organization: 2008.
47. Callen J, Georgiou A, Li J., Westbrook JI. The safety implications of missed test results for hospitalised patients: a systematic review. BMJ Qual Saf 2011; 20: 194-9.
48. Kilpatrick ES, Holding S. Use of computer terminals on wards to access emergency test results: a retrospective audit. BMJ 2001; 322:1101-3.
49. Singh H, Spitzmueller C, Petersen N., Sawhney MK, Sittig DF. Information overload and missed test results in electronic health record-based settings. JAMA Intern Med 2013; 173:702-4.
50. Turner HE, Peake RWA, Allison JJ. The impact of centrifugation in primary care on pseudohypokalaemia: a retrospective evaluation. Ann Clin Biochem 2013; 50: 371-3.
51. O'Kane MJ. The evidence base for laboratory medicine: more work needed. Ann Clin Biochem 2013; 50:293-5.
52. Bruns DE, Boyd JC. Assessing the impact ofbiomarkers on patient outcome: an obligatory step. Scand J Clin Lab Invest 2010; 70(SUPPL. 242):85-9.
53. Neumann PL, Tunis SR. Medicare and medical technology: the growing demand for relevant outcomes. N Engl J Med 2010; 362:377-9.
54. Whiting P, Rutjes AW, Reitsma J.B., Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004; 140:189-202.
55. Price CP. Evidence-based laboratory medicine: is it working in practice? Clin Biochem Rev 2012; 33:13-9.
56. Price CP, Christenson RH. Ask the right question: a criticalstep for practicing evidence-basedlaboratory medicine. Ann Clin Biochem 2013; 50:306-14.
57. Horvath AR, Lord SJ, StJohn A, Sandberg S., Cobbaert C, Lorenz S, et al. From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta 2014; 427:49-57.
58. Bossuyt PM, Reitsma JB, Linnet K, Moons KG. Beyond diagnostic accuracy: the clinical utility of diagnostic tests. Clin Chem 2012; 58:1636-43.
59. Mallett S, Halligan S, Thompson M., Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ 2012; 344:e3999.
60. Lewin Group. Laboratory medicine and comparative effectiveness research. http://www.lewin.com/publications/publication/402/ (Accessed September 2014).
61. Lord SJ, Irwig I, Bossuyt PM. Using the principles of randomized controlled trial design to guide test evaluation. Med Decis Making 2009; 29:E1-12.
62. Trikalinos TA, Siebert U, Lau J. Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations. Med Decis Making 2009; 29:E22-29.
63. Bossuyt PM, Reitsma JB, Bruns D.E., Garsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003; 49:1-6.
64. Schultz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine 2010; 8:18.
65. Agency for Healthcare Research and Quality. Methods guide for medical test reviews. Publication No. 12-EC017. Rockville; Agency for Healthcare Research and Quality: 2012. http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=558 (Accessed September 2014).
66. Whiting P, Rutjes AW, Westwood M.E., Mallett S., Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155:529-36.
67. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PMM, Deeks JJ. Assessing the valueofdiagnostic tests: a framework for designing and evaluating trials. BMJ 2012; 344:e686.
68. Institute of Medicine of the National Academies. Finding what works in health care: standards for systematic reviews. http://iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-Systematic-Reviews.aspx (Accessed September 2014).
69. Simera I, Altman DG. Writing a research article that is "fit for purpose": EQUATOR Network and reporting guidelines. Evid Based Med 2009; 14:132-4.
70. Soletormos G, Duffy MJ, Hayes D.F., Sturgeon CM, Barak V, Bossuyt PM, et al. Design of tumor biomarkermonitoring trials: aproposal by the European Group on Tumor Markers. Clin Chem 2013; 59:52-9.
71. Korevaar DA, Ochodo EA, Bossuyt PMM, Hooft L. Publication and reporting of test accuracy studies registered in ClinicalTrials.gov. Clin Chem 2014; 60:651-9.
72. Christenson RH, Snyder SR, Shaw C.S., Derzon JH, Black RS, Mass D, et al. Laboratory medicine best practices: systematicevidence review and evaluation methods for quality improvement. Clin Chem 2011; 57:816-25.
73. Kilpatrick ES, Freedman DB; National Clinical Biochemistry Audit Group. A national survey of interpretative reporting in the UK. Ann Clin Biochem 2011; 48:317-20.
74. Kilpatrick ES, Rigby AS, Atkin S.L., Barth JH. Glycemic control in the 12 months following a change to SI hemoglobin A1c reporting units. Clin Chem 2013; 59: 1457-60.
75. Misra S, Barth JH. Guidelines are written, but are they followed? Ann Clin Biochem 2013; 50:400-2.
76. Beastall GH. Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med 2013; 51:221-7.